| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |